Pulmonary Langerhans Cell Histiocytosis-associated Pulmonary Hypertension Showing a Drastic Improvement Following Smoking Cessation

Intern Med. 2016;55(5):491-5. doi: 10.2169/internalmedicine.55.5152. Epub 2016 Mar 1.

Abstract

Pulmonary Langerhans cell histiocytosis (PLCH) is a rare, smoking-related, interstitial lung disease, and pulmonary hypertension (PH) is associated with mortality. We herein report a case of PLCH complicated by severe PH and respiratory impairment. After developing PH, the patient displayed a cystic pattern on chest high-resolution computed tomography (HRCT). This, in turn, corresponded with the scarring stage of PLCH. However, the patient's PH and respiratory impairment improve dramatically following smoking cessation. PLCH patients with a cystic pattern on chest HRCT may still be able to improve their PH and respiratory impairment when they are able to quit smoking.

Publication types

  • Case Reports

MeSH terms

  • Diuretics / therapeutic use
  • Female
  • Histiocytosis, Langerhans-Cell / complications
  • Histiocytosis, Langerhans-Cell / diagnostic imaging
  • Histiocytosis, Langerhans-Cell / physiopathology*
  • Histiocytosis, Langerhans-Cell / therapy
  • Humans
  • Hypertension, Pulmonary / diagnostic imaging
  • Hypertension, Pulmonary / etiology
  • Hypertension, Pulmonary / physiopathology*
  • Hypertension, Pulmonary / therapy
  • Middle Aged
  • Respiratory Insufficiency / diagnostic imaging
  • Respiratory Insufficiency / etiology
  • Respiratory Insufficiency / physiopathology*
  • Respiratory Insufficiency / therapy
  • Smoking / adverse effects*
  • Smoking Cessation*
  • Tomography, X-Ray Computed
  • Treatment Outcome
  • Vasodilator Agents / therapeutic use

Substances

  • Diuretics
  • Vasodilator Agents